Bicalutamide and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Bicalutamide (bicalutamide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lupron Depot, and have Prostate cancer metastatic.

The phase IV clinical study analyzes which people have Stroke when taking Bicalutamide. It is created by eHealthMe based on reports of 9,859 people who have side effects when taking Bicalutamide from the FDA, and is updated regularly.

What is Bicalutamide?

Bicalutamide has active ingredients of bicalutamide. It is often used in prostate cancer. eHealthMe is studying from 9,930 Bicalutamide users. Check the latest studies of Bicalutamide.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,383 drugs and 3,010 conditions by eHealthMe. Check the latest studies of Stroke.

On Nov, 13, 2025

9,859 people reported to have side effects when taking Bicalutamide.
Among them, 73 people (0.74%) have Stroke.

Among these 73 people:

How long have people been on Bicalutamide when they have Stroke? *

What is the gender of people who have Stroke when taking Bicalutamide? *

female: 2.9 %
male: 97.1 %

What is the age of people who have Stroke when taking Bicalutamide? *

What are other drugs people take besides Bicalutamide? *

What are other side effects people have besides Stroke? *

Fall: 12 people, 16.44%
Fatigue (feeling of tiredness): 11 people, 15.07%
Weakness: 7 people, 9.59%
Dizziness: 6 people, 8.22%
Speech Impairment (Adult) (inability to speak (adult)): 6 people, 8.22%
Pneumonia: 5 people, 6.85%
Drowsiness: 5 people, 6.85%
Fainting (loss of consciousness and postural tone): 4 people, 5.48%
Renal Impairment (severely reduced kidney function): 4 people, 5.48%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 5.48%

What are the existing conditions these people have? *

Prostate Cancer Metastatic: 13 people, 17.81%
High Blood Pressure: 6 people, 8.22%
High Blood Cholesterol: 4 people, 5.48%
Diabetes: 4 people, 5.48%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 4.11%
Hiv Infection: 3 people, 4.11%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 4.11%
Cardiac Disorder: 2 people, 2.74%
Hyperkalemia (damage to or disease of the kidney): 2 people, 2.74%
Indigestion: 2 people, 2.74%

* Approximation only. Some reports may have incomplete information.

Do you take Bicalutamide and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bicalutamide:

Bicalutamide (9,930 reports)

Stroke treatments and more:

Stroke (334,631 reports)

Browse all side effects of Bicalutamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,383 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,010 conditions)

Related publications that referenced our studies

Peng, C. C., Chen, C. Y., Chen, C. R., Chen, C. J., Shen, K. H., Chen, K. C., & Peng, R. Y., "Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model", Scientific reports, 2018 Jan .
Peng, C. C., Chen, C. Y., Chen, C. R., Chen, C. J., Shen, K. H., Chen, K. C., & Peng, R. Y., "Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model", Scientific reports, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on bicalutamide (the active ingredients of Bicalutamide) and Bicalutamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.